Distinguished Scientist
Genentech, United States
Iraj Hosseini is a Distinguished Scientist in DevSci PTPK, Modeling & Simulation group. Iraj has been at Genentech since 2015 and leads the group in charge of supporting M&S efforts for the oncology portfolio from lead identification to Phase 1/2 for both the Molecular Oncology and Cancer Immunotherapy programs. In his role, Iraj has been the champion of “QSP in the Loop” and overseen a portfolio of modular oncology QSP models that have enabled accelerated decision-making for an array of modalities including Bispecifics, ADCs, Engineered Cytokines, Cancer Vaccines, and T-cell Therapies. Iraj has also led oncology programs as a phamacology team lead since 2021, overseeing the development of these programs from molecule selection and FIH dose selection to expansion dose selection, and Phase 2 Go/No-Go discussions.
Disclosure(s): Roche: Employment (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)
Monday, November 11, 2024
5:00 PM – 6:30 PM MST
Case application vignettes of QSP platform models informed by clinical data
Monday, November 11, 2024
5:00 PM – 6:00 PM MST
Tuesday, November 12, 2024
2:00 PM – 3:30 PM MST